Lung cancer resistant to Xalkori was successfully treated with ceritinib
(dailyRx News) As scientists continue to look for better and more effective cancer treatments, one new study looked at a promising new medication in the fight against lung cancer.
This new study found that the test medication ceritinib effectively shrank tumors and reduced their number in more than half of the lung cancer patients treated.
The researchers also noted that patients whose tumors had become resistant to crizotinib (Xalkori) also saw significant success rates when using ceritinib.
Read more from RxWiki HERE.